Ex-doctor found innocent in Australian cannabis treatment case
An ex-doctor in Australia has successfully defended himself in a landmark medical cannabis trial, arguing that his unauthorized treatments with cannabis compounds were of “medical…
Medical
Global cannabis stakeholders will descend on Vienna in December
Cannabis, activists, scientists, practitioners and other stakeholders will make presentations at the International Cannabis Policy Conference Dec. 7-9 in Vienna. Some 20 speakers representing 11…
Elixinol debuts on U.S. exchange as Farm Bill vote looms
Denver, Colorado-based Elixinol Global Limited today debuted on the OTCQX Best Market in the USA just ahead of anticipated changes in federal legislation that could…
Inside the HemPoland sale and what’s ahead for CBD?
About the Podcast Pilot Edition PART ONE: Jacek Kramarz, Sales Director at HemPoland, talks about the evolution of the company before it was acquired in…
Euro CBD market will grow; look for some shakeout globally
Despite significant institutional challenges, the European CBD market will see strong growth for those companies that can navigate the murky waters of EU regulation while…
GW Pharma releases pricing on newly approved CBD-drug
Insured patients in the USA would pay up to $200 per month for CBD-based drug Epidiolex under a recent pricing announcement from the maker, UK-based…
”Democratization of knowledge” will drive demand and data about medical cannabis
The monopoly on medical knowledge previously held by governments, pharma companies and the medical establishment has now been broken forever due to technological advancements and…
Reps from 10 countries will talk CBD at HT’s August biz meet-up
Health care needs to eschew a high-tech approach and go beyond the treatment of symptoms to attack the causes of chronic diseases rooted in current…
After approval of first cannabis-based drug in USA, what’s next?
Recent approval of GW Pharmaceutical’s cannabidiol-based drug Epidiolex in the United States not only will soon give patients needed relief, but can spur further research…
Europe’s Great THC Debate: Get moving or fall behind
EUROPEAN HEMP (Second of 4 parts) Part 1: Europe’s tough row to hoe: Lack of clarity on CBD, THC Upcoming: Part 3: Monday, July 2:…